For example, as one of the identified IDPs, Tau’s aggregation contributes to Alzheimer’s disease (AD) [20], and phosphorylation modification promotes the phase separation of Tau and accelerates the formation of amyloid protein [21]. The gene discussed is MAPT; the disease is Alzheimer disease.